1. Home
  2. BCRX vs EFC Comparison

BCRX vs EFC Comparison

Compare BCRX & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • EFC
  • Stock Information
  • Founded
  • BCRX 1986
  • EFC 2007
  • Country
  • BCRX United States
  • EFC United States
  • Employees
  • BCRX N/A
  • EFC N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • EFC Real Estate
  • Sector
  • BCRX Health Care
  • EFC Finance
  • Exchange
  • BCRX Nasdaq
  • EFC Nasdaq
  • Market Cap
  • BCRX 1.4B
  • EFC 1.3B
  • IPO Year
  • BCRX 1994
  • EFC 2010
  • Fundamental
  • Price
  • BCRX $6.87
  • EFC $13.57
  • Analyst Decision
  • BCRX Strong Buy
  • EFC Strong Buy
  • Analyst Count
  • BCRX 11
  • EFC 7
  • Target Price
  • BCRX $19.00
  • EFC $14.46
  • AVG Volume (30 Days)
  • BCRX 7.8M
  • EFC 1.1M
  • Earning Date
  • BCRX 11-03-2025
  • EFC 11-05-2025
  • Dividend Yield
  • BCRX N/A
  • EFC 11.32%
  • EPS Growth
  • BCRX N/A
  • EFC 1.24
  • EPS
  • BCRX N/A
  • EFC 1.33
  • Revenue
  • BCRX $599,816,000.00
  • EFC $325,401,000.00
  • Revenue This Year
  • BCRX $41.57
  • EFC N/A
  • Revenue Next Year
  • BCRX $6.25
  • EFC $8.81
  • P/E Ratio
  • BCRX N/A
  • EFC $10.34
  • Revenue Growth
  • BCRX 45.38
  • EFC 11.18
  • 52 Week Low
  • BCRX $6.00
  • EFC $11.12
  • 52 Week High
  • BCRX $11.31
  • EFC $14.40
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 43.58
  • EFC 52.59
  • Support Level
  • BCRX $6.51
  • EFC $13.10
  • Resistance Level
  • BCRX $7.22
  • EFC $14.04
  • Average True Range (ATR)
  • BCRX 0.27
  • EFC 0.24
  • MACD
  • BCRX 0.01
  • EFC 0.02
  • Stochastic Oscillator
  • BCRX 41.15
  • EFC 49.52

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: